In vitro study reveals that GPER activation promotes EMT-like invasion in glioblastoma cells, suggesting GPER signaling contributes to tumor progression.
Glioblastomas (GBs) are the most frequent and aggressive central nervous system tumors, whose progression is influenced by sex hormones. 17β-estradiol (E2), promotes an epithelial-to-mesenchymal transition (EMT)-like process and enhances proliferative, migratory, and invasive capacities in GB through intracellular estrogen receptors. However, the role of G protein-coupled estrogen receptor (GPER) in GB remains poorly understood. We evaluated the effects of E2, the GPER-agonist G-1, and the GPER-antagonist G-15 on EMT-related processes, migration, and invasion in U251 and U87 GB-derived cells. GPER activation by E2 and G-1 increased migration and invasion, whereas G-15, alone or combined, reduced these effects. GPER activation also induced a mesenchymal-like phenotype. These findings suggest that GPER-associated signaling contributes to EMT-like phenotypic changes, migration, and invasion in GB.
No takes yet. Share an insight, caveat, or question.
Peña‐Gutiérrez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: